Bafna Pharmaceuticals provides update on registration with DSIR

On 07 April 2016

Bafna Pharmaceuticals announced that the Company has been registered with Department of Scientific & Industrial Research for the purpose of availing customs /central excise duty exemption in terms of Government notification dated 01 March 2007 and central excise duty exemption in terms of notification dated 01 March 2007 and the registration is subject to conditions imposed by the DSIR. Further, the Company has got the renewal of recognition of In-house R&D units by the Department of Scientific and Industrial Research subject to the condition imposed by it.

Powered by Capital Market - Live News